M. Yasir Qureshi
Mayo Clinic
Intraclass correlationInternal medicineRadiologyMagnetic resonance imagingCardiologyFetusIn uteroCardiac magnetic resonance imagingFetal interventionVascular surgeryLiver diseaseFetal surgeryCongenital diaphragmatic herniaHeart failureCardiac surgeryVentriclePregnancyHypoplastic left heart syndromeImplantable loop recorderHeart diseaseCircumferential strainIn patientGestationMedicineEjection fraction
21Publications
5H-index
88Citations
Publications 20
Newest
Myocardial strain offers new insights into ventricular performance, There are software packages from several different companies used to ascertain this, and little data is available in patients with single right ventricle (sRV) physiology. We aimed to compare the analysis of two strain software applications using a cohort of patients with sRV for both inter-vendor and inter-observer variability. Echocardiograms from 85 patients with sRV (122 separate studies) were prospectively evaluated. All ha...
Source
Accurate assessment of the right ventricular (RV) volume and function is important in patients with hypoplastic left heart syndrome (HLHS). We sought to investigate the effect of ventriculotomy on the correlation of RV functional assessments by two-dimensional echocardiography (2DE) to cardiac magnetic resonance (CMR)-derived RV ejection fraction (EF) in patients with HLHS. A retrospective re-analysis of CMR imaging with matched 2DE was performed from the institutional HLHS registry. Echocardiog...
Source
Source
#1Ram K. Rohatgi (Mayo Clinic)H-Index: 8
#2M. Yasir Qureshi (Mayo Clinic)H-Index: 5
Last. Nathaniel W. Taggart (Mayo Clinic)H-Index: 14
view all 3 authors...
Source
Left ventricular (LV) morphology may affect right ventricular (RV) function before and after Fontan palliation in patients with hypoplastic left heart syndrome (HLHS). We sought to assess the potential impact of LV morphology on RV function in patients with HLHS using cardiac magnetic resonance (CMR) imaging. A retrospective analysis of available CMR scans from all patients with HLHS was performed. LV morphology was categorized as absent/slit-like or globular/miniaturized. Volumetric analysis wa...
1 CitationsSource
#1Jeanne L. Theis (Mayo Clinic)H-Index: 11
#2Jessie J. Hu (Mayo Clinic)H-Index: 1
Last. Timothy M. Olson (Mayo Clinic)H-Index: 31
view all 8 authors...
BACKGROUND Hypoplastic left heart syndrome (HLHS) with risk of poor outcome has been linked to MYH6 variants, implicating overlap in genetic etiologies of structural and myopathic heart disease. METHODS Whole genome sequencing was performed in 197 probands with HLHS, 43 family members, and 813 controls. Data were filtered for rare, segregating variants in 3 index families comprised of an HLHS proband and relative(s) with cardiomyopathy. Whole genome sequencing data from cases and controls were c...
1 CitationsSource
#1Rodrigo Ruano (Mayo Clinic)H-Index: 12
#2Eniola R. Ibirogba (Mayo Clinic)H-Index: 4
Last. Denise B. Klinkner (Mayo Clinic)H-Index: 6
view all 13 authors...
Introduction In utero interventions are performed in fetuses with "isolated" major congenital anomalies to improve neonatal outcomes and quality of life. Sequential in utero interventions to treat 2 anomalies in 1 fetus have not yet been described. Case presentation Here, we report a fetus with a large left-sided intralobar bronchopulmonary sequestration (BPS) causing mediastinal shift, a small extralobar BPS, and concomitant severe left-sided congenital diaphragmatic hernia (CDH). At 26-week ge...
Source
#1Marie Vincenti (Mayo Clinic)H-Index: 1
#2Patrick W. O'Leary (Mayo Clinic)H-Index: 40
Last. Joan Wobig (Mayo Clinic)H-Index: 1
view all 7 authors...
Preservation of right ventricle function (RV) is a key to favorable outcome in Hypoplastic Left Heart Syndrome (HLHS), but methods to preserve or improve RV function are limited. Our goal was to assess the clinical and functional impact of autologous umbilical cord blood-derived mononuclear cells (UCB-MNC) therapy when given to patients with HLHS at Stage II surgery. UCB-MNC patients were enrolled prospectively in a phase I, FDA monitored trial as previously described (Burkhart et al., 2019). Ma...
2 CitationsSource
#1Sharon L. Paige (Stanford University)H-Index: 14
#2Francisco X. Galdos (Stanford University)H-Index: 5
Last. Sean M. Wu (Stanford University)H-Index: 36
view all 20 authors...
4 CitationsSource
Source